Evidence map›Paper›PMID 35947353›Full record

ArticleCurrent topics in behavioral neurosciences2023

The Microbiome and Mental Health Across the Lifespan.

Faith Dickerson, Amanda Hazel Dilmore, Filipa Godoy-Vitorino, Tanya T Nguyen, Martin Paulus, Adrian A Pinto-Tomas, Cristofer Moya-Roman, Ibrahim Zuniga-Chaves, Emily G Severance, Dilip V Jeste

Abstract read
PubMed Publisher
In one paragraph

Article in Current topics in behavioral neurosciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 3 countries.

Faith DickersonSheppard Pratt, Baltimore, MD, USA. fdickerson@sheppardpratt.org.
Amanda Hazel DilmoreBiomedical Sciences Graduate Program, University of California, San Diego, CA, USA.
Filipa Godoy-VitorinoDepartment of Microbiology and Medical Zoology, University of Puerto Rico School of Medicine, San Juan, PR, USA.
Tanya T NguyenSam and Rose Stein Institute for Research on Aging, University of California, San Diego, CA, USA.
Martin PaulusLaureate Institute for Brain Research, Tulsa, OK, USA.
Adrian A Pinto-TomasUniversity of Costa Rica, San Jose, CR, USA.
Cristofer Moya-RomanUniversity of Costa Rica, San Jose, CR, USA.
Ibrahim Zuniga-ChavesDepartment of Bacteriology, Microbial Doctoral Training Program, University of Wisconsin-Madison, Madison, WI, USA.
Emily G SeveranceStanley Neurovirology Laboratory, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Dilip V JesteSam and Rose Stein Institute for Research on Aging, University of California, San Diego, CA, USA.
Institute on Aging · USUniversidad de Costa Rica · CRJohns Hopkins University · USLaureate Institute for Brain Research · USSheppard and Enoch Pratt Hospital · USUniversity of California, San Diego · USUniversity of Puerto Rico, Medical Sciences Campus · PRUniversity of Wisconsin–Madison · US

Funding

Tracking and Evaluation CoreU54GM133807 · NIGMS · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI PORTER, JAMES T. · 2020 to 2024
$17.7M
6 · The paper itself

Abstract

introductionThe combined genetic material of the microorganisms in the human body, known as the microbiome, is being increasingly recognized as a major determinant of human health and disease. Although located predominantly on mucosal surfaces, these microorganisms have profound effects on brain functioning through the gut-brain axis.

methodThe content of the chapter is based on a study group session at the annual meeting of the American College of Neuropsychopharmacology (ACNP). The objective was to discuss the emerging relationship between the human microbiome and mental health as relevant to ACNP's interests in developing and evaluating novel neuropsychiatric treatment strategies. The focus is on specific brain disorders, such as schizophrenia, substance use, and Alzheimer's disease, as well as on broader clinical issues such as suicidality, loneliness and wisdom in old age, and longevity.

resultsStudies of schizophrenia indicate that the microbiome of individuals with this disorder differs from that of non-psychiatric comparison groups in terms of diversity and composition. Differences are also found in microbial metabolic pathways. An early study in substance use disorders found that individuals with this disorder have lower levels of beta diversity in their oral microbiome than a comparison group. This measure, along with others, was used to distinguish individuals with substance use disorders from controls. In terms of suicidality, there is preliminary evidence that persons who have made a suicide attempt differ from psychiatric and non-psychiatric comparison groups in measures of beta diversity. Exploratory studies in Alzheimer's disease indicate that gut microbes may contribute to disease pathogenesis by regulating innate immunity and neuroinflammation and thus influencing brain function. In another study looking at the microbiome in older adults, positive associations were found between wisdom and alpha diversity and negative associations with subjective loneliness. In other studies of older adults, here with a focus on longevity, individuals with healthy aging and unusually long lives had an abundance of specific microorganisms which distinguished them from other individuals. DISCUSSION: Future studies would benefit from standardizing methods of sample collection, processing, and analysis. There is also a need for the standardized collection of relevant demographic and clinical data, including diet, medications, cigarette smoking, and other potentially confounding factors. While still in its infancy, research to date indicates a role for the microbiome in mental health disorders and conditions. Interventions are available which can modulate the microbiome and lead to clinical improvements. These include microbiome-altering medications as well as probiotic microorganisms capable of modulating the inflammation in the brain through the gut-brain axis. This research holds great promise in terms of developing new methods for the prevention and treatment of a range of human brain disorders.

Indexed as

Alzheimer DiseaseMicrobiotaSchizophreniaAgedHumansLongevityMental HealthAgingBeta diversityMental healthMicrobiomeMicroorganismsProbiotics

Identifiers

PMID35947353
OpenAlexW4291737382

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.